Published in Physician Law Weekly, February 7th, 2007
Researchers at the Stanford Prevention Research Center are looking for regular smokers to try a skin patch that delivers a medication used to treat depression. The drug, selegiline, could help smokers combat the cravings they feel when they try to quit, said study leader Joel Killen, PhD, professor of medicine.
The medication, which is marketed under the name Emsam, is produced by Somerset Pharmaceuticals and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly